NCT02540408

Brief Summary

A pilot study from the investigators group suggests that the prevalence of chronic obstructive pulmonary disease (COPD) among dairy farmers is higher than in the general population. Most characteristics of COPD in dairy farmers (smoking habits, dyspnoea, quality of life, lung function, bronchial exhaled nitric oxide, systemic inflammation, arterial stiffness and exercise capacity) are largely unknown. Although immunization against organic dusts is suspected, the pathophysiology of COPD in dairy farmers is also unknown. This study therefore aims at (i) comparing the prevalence of COPD in dairy farmers and in subjects without any occupational exposure (control arm) through a vast COPD detection program in the Franche-Comté region; (ii) comparing several characteristics (smoking habits, dyspnoea, quality of life, lung function, bronchial exhaled nitric oxide, systemic inflammation, arterial stiffness and exercise capacity) between dairy farmers with COPD and patients with COPD without any occupational exposure; (iv) identifying etiological factors of COPD in dairy farmers (comparison of exposure and specific immunoglobulin E between dairy farmers with COPD and dairy farmers with normal pulmonary function tests); and (v) constituting a cohort of COPD patients and control subjects for further longitudinal studies. Data from selected patients (either current or former smokers) with mild COPD and from matched controls will also be analyzed in an ancillary study which objectives are to compare exercise tolerance, ventilatory constraints on tidal volume expansion and dyspnoea between asymptomatic mild COPD subjects, symptomatic mild COPD and healthy controls.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
400

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Nov 2011

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2011

Completed
1.8 years until next milestone

First Submitted

Initial submission to the registry

August 29, 2013

Completed
2 years until next milestone

First Posted

Study publicly available on registry

September 4, 2015

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2015

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2015

Completed
Last Updated

February 8, 2016

Status Verified

September 1, 2015

Enrollment Period

4 years

First QC Date

August 29, 2013

Last Update Submit

February 5, 2016

Conditions

Keywords

Occupational COPDPathophysiologyExercise limitationPulmonary hyperinflationArterial stiffness

Outcome Measures

Primary Outcomes (1)

  • prevalence of COPD in dairy farmers and in unexposed subjects

    3-year

Secondary Outcomes (9)

  • comparison of smoking habits between dairy farmers with COPD and unexposed COPD

    4-year

  • comparison of dyspnoea between dairy farmers with COPD and unexposed COPD

    4-year

  • comparison of lung function between dairy farmers with COPD and unexposed COPD

    4-year

  • comparison of bronchial exhaled nitric oxide between dairy farmers with COPD and unexposed COPD

    4-year

  • comparison of systemic inflammation between dairy farmers with COPD and unexposed COPD

    4-year

  • +4 more secondary outcomes

Other Outcomes (4)

  • comparison of dyspnoea between asymptomatic mild COPD subjects, symptomatic mild COPD and healthy controls

    2-year

  • comparison of exercise tolerance dyspnoea between asymptomatic mild COPD subjects, symptomatic mild COPD and healthy controls

    2-year

  • comparison of ventilatory constraints on tidal volume expansion between asymptomatic mild COPD subjects, symptomatic mild COPD and healthy controls

    2-year

  • +1 more other outcomes

Study Arms (1)

presence of COPD

COPD patients are defined according to the results of a spirometry

Eligibility Criteria

Age40 Years - 74 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

COPD patients will be defined according to the GOLD criteria (post-bronchodilator FEV1/FVC ratio\<70%). Healthy subjects must have pre-bronchodilator FEV1/FVC ratio \>75% and pre-bronchodilator FEV1 \>95% of predicted value.

You may qualify if:

  • subject aged 40-74 years
  • either dairy farmer or unexposed to any occupational risk factor for COPD

You may not qualify if:

  • COPD in GOLD stage 4
  • pregnancy
  • treatment with systemic corticosteroids
  • established diagnosis of asthma
  • established diagnosis of bronchiectasis
  • established diagnosis of allergic alveolitis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU Jean Minjoz

Besançon, 25030, France

Location

Related Publications (2)

  • Degano B, Bouhaddi M, Laplante JJ, Botebol M, Annesi-Maesano I, Marescaux A, Roux P, Thaon I, Wolf JP, Regnard J, Dalphin JC. [COPD in dairy farmers: screening, characterization and constitution of a cohort. The BALISTIC study]. Rev Mal Respir. 2012 Nov;29(9):1149-56. doi: 10.1016/j.rmr.2012.08.007. Epub 2012 Oct 15. French.

    PMID: 23200591BACKGROUND
  • Veil-Picard M, Soumagne T, Vongthilath R, Annesi-Maesano I, Guillien A, Laurent L, Andujar P, Roche N, Jouneau S, Cypriani B, Laplante JJ, Degano B, Dalphin JC. Is atopy a risk indicator of chronic obstructive pulmonary disease in dairy farmers? Respir Res. 2019 Jun 17;20(1):124. doi: 10.1186/s12931-019-1082-2.

Biospecimen

Retention: SAMPLES WITHOUT DNA

Serum for further analyses

MeSH Terms

Conditions

Pulmonary Disease, Chronic Obstructive

Condition Hierarchy (Ancestors)

Lung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Bruno Degano, MD, PhD

    CHU Besançon

    PRINCIPAL INVESTIGATOR
  • Jean-Charles Dalphin, MD, PhD

    CHU Besançon

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 29, 2013

First Posted

September 4, 2015

Study Start

November 1, 2011

Primary Completion

November 1, 2015

Study Completion

November 1, 2015

Last Updated

February 8, 2016

Record last verified: 2015-09

Locations